Finding out if someone has a short stature homeobox gene mutation involves careful physical examination, imaging studies, and genetic testing. Early and accurate diagnosis helps doctors understand the cause of short stature and skeletal differences, allowing families to make informed decisions about treatment and management options.

Introduction: Who Should Undergo Diagnostics

Diagnostic testing for SHOX deficiency, which is a condition caused by problems with the short stature homeobox-containing gene, is most important for children and adults who show signs of short stature along with certain skeletal features. The SHOX gene plays an essential role in bone growth and development, particularly in the arms and legs. When this gene is not working properly, it can lead to a range of physical differences that vary from person to person.^[1]

Parents should consider seeking medical evaluation if their child is much shorter than other children of the same age and sex. This is especially important if the child also shows other signs such as shortened forearms or lower legs, unusual positioning of the elbows or knees, or differences in the wrists and forearms. However, short stature alone can have many different causes, so it is important to work with a doctor to understand what might be happening.^[3]

Children whose growth has dropped significantly on their growth chart should also be evaluated. For example, if a child was previously growing along the 25th percentile but has dropped to below the 3rd percentile, this change in growth pattern can signal that something needs medical attention. Doctors call this “growth failure,” and it can indicate the presence of an underlying medical condition.^[3]

Families with a history of short stature across multiple generations should also consider testing. Because SHOX deficiency can be passed from parent to child, knowing about a family pattern of short stature with similar skeletal features can be an important clue. Sometimes parents or other relatives may have had the same condition but were never formally diagnosed.^[5]

Girls diagnosed with Turner syndrome, a condition where one X chromosome is missing or altered, should also be evaluated for SHOX deficiency. Because the SHOX gene is located on the sex chromosomes, most girls with Turner syndrome have only one copy of the gene instead of the usual two. This shortage of the SHOX protein likely contributes to the short stature and skeletal differences commonly seen in this condition.^[1]

Classic Diagnostic Methods

The process of diagnosing SHOX deficiency typically begins with a thorough physical examination by a pediatrician or a specialist called a pediatric endocrinologist, who focuses on growth and hormonal conditions in children. During this examination, the doctor will carefully measure the child’s height, weight, and body proportions. They will pay special attention to the length of the arms and legs compared to the trunk, looking for a pattern called mesomelia, where the middle portions of the limbs (the forearms and lower legs) are shortened relative to the upper portions.^[3]

The doctor will also measure the child’s arm span, which is the distance from fingertip to fingertip when the arms are stretched out to the sides. In children with SHOX deficiency, the arm span is often shorter than the height, which is the opposite of what is typically seen in healthy children. This difference can be an important clue pointing toward SHOX deficiency.^[5]

Physical examination also includes looking for specific skeletal features. One of the most characteristic signs is Madelung deformity, an abnormality of the wrist and forearm bones that typically develops during mid-to-late childhood. In this condition, the bones of the wrist and forearm do not align properly, which can cause the wrist to appear bent or angled. The doctor may notice that the child’s elbows are turned outward or that the knees are turned inward. Other features might include bowed shinbones, short feet, a short neck, or a smaller lower jaw.^[3]

X-ray imaging is an essential tool in the diagnostic process. Doctors will typically order X-rays of the child’s hands and wrists to look for Madelung deformity and to assess bone age. Bone age is determined by looking at how mature the bones appear compared to what is typical for the child’s chronological age. In some cases, the bone age may be younger or older than expected, providing additional information about growth patterns.^[9]

X-rays of other parts of the skeleton may also be taken to look for additional features of SHOX deficiency. These might include X-rays of the arms, legs, spine, or feet. The radiologist and doctor will look for characteristic patterns such as shortened long bones, unusual bone shapes, or irregular growth regions in the bones. These images help distinguish SHOX deficiency from other conditions that can cause short stature.^[11]

Laboratory blood tests are often performed to rule out other causes of short stature. These tests typically include checking thyroid function, as thyroid disorders can affect growth. Doctors may also test for growth hormone deficiency by performing stimulation tests, where the child is given a substance that should trigger the release of growth hormone, and then blood levels are measured. If growth hormone levels are normal, this helps point toward other causes like SHOX deficiency.^[9]

A chromosome test called karyotyping may be performed, especially in girls, to rule out Turner syndrome. This test examines the structure and number of chromosomes to see if there are any abnormalities. A normal female karyotype is 46,XX, while a normal male karyotype is 46,XY. If Turner syndrome is found, SHOX deficiency is more likely because most females with Turner syndrome have only one copy of the SHOX gene.^[9]

The definitive diagnosis of SHOX deficiency is made through genetic testing. Two main types of genetic tests are used. The first is Sanger sequencing, which looks for mutations or changes in the DNA code of the SHOX gene itself. This can detect small changes in the gene that might prevent it from working properly. The second type is multiplex ligation-dependent probe amplification (MLPA), which is used to detect deletions (missing pieces) or duplications (extra copies) of the SHOX gene or nearby regions that help regulate the gene’s activity.^[5]

Deletions are actually the most common type of genetic change found in people with SHOX deficiency. These deletions can involve the entire SHOX gene or just parts of it. Sometimes the deletion affects nearby genetic material that acts as an enhancer region, which is a piece of DNA that helps control when and how much of the SHOX protein is made. Even though the gene itself might be intact, if the enhancer region is deleted, the gene cannot work properly.^[3]

More than 380 different mutations in the SHOX gene have been identified in people with short stature and related conditions. These mutations are scattered throughout the gene’s coding regions. Some mutations are “nonsense” mutations that cause the protein production to stop early, while others are “frameshift” mutations that change how the genetic code is read, leading to an abnormal protein.^[5]

The severity of symptoms can vary even among people with the same genetic change. At the severe end of the spectrum is a condition called Langer mesomelic dysplasia, which occurs when both copies of the SHOX gene are affected (one from each parent). This leads to very short stature and extreme shortening of the long bones. At the milder end is Léri-Weill dyschondrosteosis, which occurs when only one copy of the gene is affected. In between these is what doctors call “SHOX-deficient short stature,” where affected individuals have short stature but may not have obvious skeletal abnormalities.^[3]

Diagnostics for Clinical Trial Qualification

When individuals with SHOX deficiency are being considered for participation in clinical trials, additional diagnostic criteria and tests are typically required beyond the standard diagnostic workup. Clinical trials are research studies that test new treatments or gather more information about existing treatments, and they have specific requirements to ensure that the right patients are enrolled and that the results are meaningful.^[7]

For enrollment in clinical trials studying treatments for SHOX deficiency, genetic confirmation is absolutely essential. Participants must have documented evidence of either a pathogenic variant (mutation) in the SHOX gene or a deletion, duplication, or insertion affecting the SHOX coding region or its regulatory enhancer regions. This genetic confirmation must come from a certified laboratory that follows established testing protocols.^[3]

Precise height measurements are critical for clinical trial eligibility and monitoring. Trials typically require that the child’s height be measured multiple times using standardized techniques to ensure accuracy. The height is then converted to a standard deviation score (SDS), which compares the child’s height to what is typical for children of the same age and sex. Many trials require that children have a height SDS below a certain threshold, often below -2.0 or -2.5, to be eligible for enrollment.^[15]

Body proportion measurements are also important in clinical trial screening. Researchers will carefully measure the arm span and compare it to height, calculate the sitting height compared to leg length, and assess the ratio of extremities to trunk. These measurements help classify the severity of the condition and determine whether the individual’s skeletal features match the trial’s inclusion criteria.^[5]

Bone age assessment is another standard requirement for clinical trials. An X-ray of the left hand and wrist is taken, and a radiologist uses standardized methods (usually the Greulich-Pyle method) to determine how mature the bones appear. This bone age is compared to the child’s chronological age. Children whose bones are too mature may not be eligible for certain trials because there may be limited remaining growth potential.^[9]

Growth velocity measurements are often required before enrollment. Growth velocity refers to how fast a child is growing over a specific period, usually measured in centimeters per year. Clinical trials may require documentation of the child’s growth rate over the previous six months to one year. This helps establish a baseline that can be compared to growth during the trial.^[7]

Clinical trials studying growth hormone treatment for SHOX deficiency typically require testing to rule out growth hormone deficiency. This involves performing growth hormone stimulation tests where the child is given medications that should trigger growth hormone release, and then multiple blood samples are taken to measure growth hormone levels. Children must have normal growth hormone responses to be classified as having SHOX deficiency rather than growth hormone deficiency.^[9]

Additional blood tests may be required to assess overall health and rule out other medical conditions that could affect growth or interfere with treatment. These might include complete blood counts, kidney function tests, liver function tests, thyroid function tests, and tests for celiac disease or other conditions that can cause growth problems.^[3]

Some clinical trials require detailed imaging beyond standard X-rays. This might include specialized X-rays of the wrists and forearms to document and measure Madelung deformity, or X-rays of the entire skeleton to look for other skeletal features. In some research settings, more advanced imaging like CT scans or MRI might be used to get detailed three-dimensional views of bone structure, though these are less common in routine clinical care.^[11]

Documentation of family history is often required for clinical trial enrollment. Researchers may ask for detailed information about the heights of parents, siblings, and other relatives, and whether any family members have been diagnosed with SHOX deficiency or related conditions. In some cases, genetic testing of family members may be offered or required to better understand inheritance patterns.^[16]

For trials studying treatments other than growth hormone, additional specialized tests may be required. For example, if a trial is studying treatments for Madelung deformity or wrist pain, detailed functional assessments of wrist mobility and pain levels might be necessary. These could include physical examination measurements of range of motion, grip strength testing, or questionnaires about how wrist problems affect daily activities.^[3]

Clinical trials also typically require regular monitoring visits during the study period. At these visits, growth measurements are repeated using the same standardized methods, blood tests may be performed to monitor for any side effects of treatment, and X-rays may be repeated to assess changes in bone maturity. All of these repeated measurements help researchers determine whether the treatment being studied is effective and safe.^[15]